Navigation Links
GenTel to distribute cancer research tool

Madison, Wis. - A research tool from Michigan used in the study of some forms of cancer is almost ready for commercialization, and a Madison-based producer of protein microarray technologies is preparing to distribute it.

The novel technology, developed at the Van Andel Research Institute of Grand Rapids, measures variation......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 08/15/06


Page: 1

Related biology technology :

1. GenTel acquires GlaxoSmithKline chip platform
2. New angel capital centered on GenTel agreement with big pharma
3. GenTel licenses next generation cancer research
4. GenTel gets federal grant to develop allergy test
5. Madisons GenTel partners with Taiwan firm
6. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
7. GenTel BioSurfaces launches new assay platform
8. GenTel will sell Dutch firms biomolecule labeling technology
9. Bone Care, GenTel, MyWeather
10. GenTel receives $250,000 state loan
11. GenTel claims $900,000 in federal grants this year for biochip research
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: GenTel distribute cancer research tool

(Date:12/16/2009)... among historians, journalists and politicians, and has been recounted ... U.S. Congress: British forces used chemical weapons on Iraqis ... claim has never been fully squared with the historical ... University. According to Douglas,s research, forthcoming in the December ... no such incident ever occurred. , Allegations of ...
(Date:12/16/2009)... of East Anglia (UEA) could contribute to the development ... generate clean electricity. , Published today by the leading ... Sciences (PNAS), the researchers have demonstrated for the ... by ,breathing rocks,. , The findings could be applied ... such as fuel cells, or ,bio-batteries, powered by animal ...
(Date:12/16/2009)... major cause of death from roadside bombs to freeway ... people age 4 to 44, often overwhelms the body,s ... the natural process, a team led by Erin Lavik, ... and her former doctoral student, James P. Bertram, built ... external bleeding., Their work is published in Science ...
(Date:12/16/2009)... 16 Martek Biosciences Corporation (Nasdaq: MATK ... quarter and fiscal year ended October 31, 2009. Revenues ... from $90.4 million in the fourth quarter of fiscal ... diluted share, for the fourth quarter of fiscal 2009, ... per diluted share, in last year,s fourth quarter. ...
Breaking Biology Technology:Despite claims, UK did not gas Iraqis in the 1920s, new research finds 2Despite claims, UK did not gas Iraqis in the 1920s, new research finds 3Despite claims, UK did not gas Iraqis in the 1920s, new research finds 4'Rock-breathing' bacteria could generate electricity and clean up oil spills 2Researchers take the inside route to halt bleeding 2Martek Announces Fourth Quarter and FY 2009 Financial Results 2Martek Announces Fourth Quarter and FY 2009 Financial Results 3Martek Announces Fourth Quarter and FY 2009 Financial Results 4Martek Announces Fourth Quarter and FY 2009 Financial Results 5Martek Announces Fourth Quarter and FY 2009 Financial Results 6Martek Announces Fourth Quarter and FY 2009 Financial Results 7Martek Announces Fourth Quarter and FY 2009 Financial Results 8Martek Announces Fourth Quarter and FY 2009 Financial Results 9Martek Announces Fourth Quarter and FY 2009 Financial Results 10Martek Announces Fourth Quarter and FY 2009 Financial Results 11Martek Announces Fourth Quarter and FY 2009 Financial Results 12Martek Announces Fourth Quarter and FY 2009 Financial Results 13Martek Announces Fourth Quarter and FY 2009 Financial Results 14
... Merger With Integra on October 11, ... ... 5 IsoTis, Inc.,(NASDAQ: ISOT ) ("IsoTis"), an orthobiologics company, ... Securities and,Exchange Commission ("SEC") in connection with the IsoTis-Integra,LifeSciences Holdings Corporation ...
... Billion in Sales by 2016, According to a ... New Report from Decision Resources, WALTHAM, ... research and advisory firms for pharmaceutical and,healthcare issues, finds that Amgen, ... $14 billion in 2006, and Genentech,the second leading biologics manufacturer with ...
... /PRNewswire/ - GenoLogics, a leading developer ... for life sciences research,announced today the ... Program, and its Geneus product has,achieved ... (Nasdaq:,AFFX) GeneChip(R) microarray platform. GenoLogics has ...
Other Biology Technology:IsoTis Files Definitive Proxy Statement 2IsoTis Files Definitive Proxy Statement 3IsoTis Files Definitive Proxy Statement 4Amgen and Genentech Brace Themselves for Heavy Pressure From Biogenerics Manufacturers 2GenoLogics' Geneus Achieves GeneChip-compatible(TM) Status with the Affymetrix GeneChip(R) Microarray Platform 2GenoLogics' Geneus Achieves GeneChip-compatible(TM) Status with the Affymetrix GeneChip(R) Microarray Platform 3
(Date:12/17/2009)... calendar and don,t miss this important scientific event, ... IOF has adopted a long term plan for ... create strong regional structures based on collaboration among ... includes the organization of Regional Scientific Meetings. , ... IOF Regional Meeting will be held in Singapore, ...
(Date:12/17/2009)... Dec. 17, 2009 The Juvenile Diabetes Research Foundation, ... worldwide, said today that it will begin working with ... Technology, and its affiliates, to speed the development of ... function of insulin-producing cells in people who have diabetes. ... academic centers around the world that could eventually lead ...
(Date:12/17/2009)... extinction like the previous five, each of which wiped out ... then North American mammals are one-fifth to one-half the way ... State University analysis. , Many scientists warn that the perfect ... result of human activity is leading to a ... occurred over the past 450 million years, the last of ...
Breaking Biology News(10 mins):JDRF announces diabetes research program with Johnson & Johnson 2Study shows loss of 15-42 percent of mammals in North America 2Study shows loss of 15-42 percent of mammals in North America 3Over half of people with rheumatoid arthritis have periodontitis 48758 1Over half of people with rheumatoid arthritis have periodontitis 48758 2Over half of people with rheumatoid arthritis have periodontitis 48758 3Appetite stimulating hormone is first potential medical treatment for frailty in older women 48756 1Appetite stimulating hormone is first potential medical treatment for frailty in older women 48756 2New MedPredict Report Reveals Top Alzheimers Experts Insights on Diagnostics and Treatments in Development Pipeline 12601 1New MedPredict Report Reveals Top Alzheimers Experts Insights on Diagnostics and Treatments in Development Pipeline 12601 2
... a calcium-sensing enzyme already known to play a role ... showed that the enzyme, calmodulin kinase II (CaM kinase ... called Timothy syndrome and that inhibiting the enzyme prevents ... new cellular model, could help with developing treatments for ...
... can have significant impacts on high-elevation lakes and imperiled ... to U.S. Forest Service and University of California, Berkeley, ... the journal " Herpetological Conservation and Biology " where ... drying up in summer and predation by introduced trout ...
... conducted at The University of Queensland could contribute to ... Nile virus and Dengue fever. , Led by ... UQ,s School of Molecular and Microbial Sciences identified a ... diseases belong. , The team found all flaviviruses ...
Other Biology News:Rare disease provides clues about enzyme role in arrhythmias 2Rare disease provides clues about enzyme role in arrhythmias 3Climate change effects on imperiled Sierra frog examined 2UQ research targets West Nile virus and dengue fever 2
Request Info...
Prepared in distilled water....
... Avidin is chromatographically purified from egg white. ... is 15.5.The product is in 10 mM ... bovine serum albumin, 0.05% sodium azide and 50% ... FITC. The conjugate is purified by molecular ...
NM522 contains an F episome, which is required for production of ssDNA and for blue/white color selection. To maintain the F, NM522 should be grown on minimal (M-9) medium....
Biology Products: